Skip to main content
. Author manuscript; available in PMC: 2009 Jun 9.
Published in final edited form as: Cancer Res. 2005 Sep 1;65(17):7707–7716. doi: 10.1158/0008-5472.CAN-05-0101

Figure 1.

Figure 1

A, relative mRNA expression of FP receptor and VEGF in endometrial adenocarcinoma (n = 25) and normal endometrium (n = 10) as determined by real-time quantitative RT-PCR analysis. B, localization of the site of expression of FP receptor (red) and VEGF (green) and colocalization of FP receptor with VEGF (merged; yellow) in poorly (P), moderately (M), and well-differentiated (W) endometrial adenocarcinomas, respectively. Arrow, blood vessel under high magnification. Bar, 100 μm. C, localization of the site of expression of FP receptor (red) and CD31 (green) and colocalization of FP receptor with CD31 (merged; yellow) in the endothelial cells of the blood vessels. Representative sample of a moderately differentiated adenocarcinoma. Insets, negative controls. Bar, 10 μm. P < 0.05, b is significantly different from a.